Modulation of 5-fluorouracil/leucovorin by trimetrexate - did it work?

被引：1

作者：

Bertino, JR ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

来源：

ANNALS OF ONCOLOGY | 2002年 / 13卷 / 01期

关键词：

D O I：

10.1093/annonc/mdf086

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：10 / 11

页数：2

共 11 条

[1] Phase II study of trimetrexate, fluorouracil, and leucovorin for advanced colorectal cancer [J].

Blanke, CD ;

Kasimis, B ;

Schein, P ;

Capizzi, R ;

Kurman, M .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :915-920

[2] A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer [J].

Blanke, CD ;

Shultz, J ;

Cox, J ;

Modiano, M ;

Isaacs, R ;

Kasimis, B ;

Schilsky, R ;

Fleagle, J ;

Moore, M ;

Kemeny, N ;

Carlin, D ;

Hammershaimb, L ;

Haller, D .

ANNALS OF ONCOLOGY, 2002, 13 (01) :87-91

[3] TRIAL OF SEQUENTIAL TRIMETREXATE, FLUOROURACIL, AND HIGH-DOSE LEUCOVORIN IN PREVIOUSLY TREATED PATIENTS WITH GASTROINTESTINAL CARCINOMA [J].

CONTI, JA ;

KEMENY, N ;

SEITER, K ;

GOKER, E ;

TONG, W ;

ANDRE, M ;

RAGUSA, K ;

BERTINO, JR .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) :695-700

[4] Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer [J].

de Gramont, A ;

Figer, A ;

Seymour, M ;

Homerin, M ;

Hmissi, A ;

Cassidy, J ;

Boni, C ;

Cortes-Funes, H ;

Cervantes, A ;

Freyer, G ;

Papamichael, D ;

Le Bail, N ;

Louvet, C ;

Hendler, D ;

de Braud, F ;

Wilson, C ;

Morvan, F ;

Bonetti, A .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :2938-2947

[5] Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial [J].

Douillard, JY ;

Cunningham, D ;

Roth, AD ;

Navarro, M ;

James, RD ;

Karasek, P ;

Jandik, P ;

Iveson, T ;

Carmichael, J ;

Alakl, M ;

Gruia, G ;

Awad, L ;

Rougier, P .

LANCET, 2000, 355 (9209) :1041-1047

[6] Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer [J].

Giacchetti, S ;

Perpoint, B ;

Zidani, R ;

Le Bail, N ;

Faggiuolo, R ;

Focan, C ;

Chollet, P ;

Llory, JF ;

Letourneau, Y ;

Coudert, B ;

Bertheaut-Cvitkovic, F ;

Larregain-Fournier, D ;

Le Rol, A ;

Walter, S ;

Adam, R ;

Misset, JL ;

Lévi, F .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (01) :136-147

[7] Integrated analysis of overall survival in two randomised studies comparing 5-fluorouracil/leucovorin with or without trimetrexate in advanced colorectal cancer [J].

Punt, CJA ;

Blanke, CD ;

Zhang, J ;

Hammershaimb, L .

ANNALS OF ONCOLOGY, 2002, 13 (01) :92-94

[8] Trimetrexate as biochemical modulator of 5-fluorouracil/leucovorin in advanced colorectal cancer:: final results of a randomised European study [J].

Punt, CJA ;

Keizer, HJ ;

Douma, J ;

Skovsgaard, T ;

Schüller, J ;

Muller, EW ;

Ten Napel, CHH ;

Croles, JJ ;

Lochs, H ;

Zhang, J ;

Hammershaimb, L .

ANNALS OF ONCOLOGY, 2002, 13 (01) :81-86

[9] LEUCOVORIN ENHANCES CYTOTOXICITY OF TRIMETREXATE FLUOROURACIL, BUT NOT METHOTREXATE FLUOROURACIL, IN CCRF-CEM CELLS [J].

ROMANINI, A ;

LI, WW ;

COLOFIORE, JR ;

BERTINO, JR .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (13) :1033-1038

[10] Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. [J].

Saltz, LB ;

Cox, JV ;

Blanke, C ;

Rosen, LS ;

Fehrenbacher, L ;

Moore, MJ ;

Maroun, JA ;

Ackland, SP ;

Locker, PK ;

Pirotta, N ;

Elfring, GL ;

Miller, LL .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (13) :905-914

← 1 2 →